Additional risk factors add to cost of AF in the USA

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.640, 2011-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment and Control of BP and Lipids in Patients with Hypertension and Additional Risk Factors

By Welch Verna

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 5, 2007-01 ,pp. : 381-389

Adis International

Access to resources Recommend Favorite

NSAIDs tied to AF risk

Reactions Weekly, Vol. 1, Iss. 1360, 2011-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Ibutilide plus magnesium cost effective for AF

Inpharma, Vol. 1, Iss. 1452, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Ibutilide plus magnesium cost effective for AF

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 460, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

European AF patients at risk due to missed opportunities

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 619, 2011-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite